| Variables |
Males
33 (67.3%) |
Females
16 (32.7%) |
Total
49 |
p value# |
| Median Age (years) |
18 (16-33) |
23.5 (17-37) |
19 (16-37) |
< .001* |
| Number of cycles |
1 (1-1) |
1 (1-3) |
1 (1-3) |
.011* |
| Months of the first cycle |
5 (1-6) |
5 (1-6) |
5 (1-6) |
.899* |
| Dose/kg (mg/kg/die) |
0.4 (0.2-0-6) |
0.4 (0.3-0.5) |
0.4 (0.2-0-6) |
.727* |
| Familiar history of acne vulgaris |
No |
11 (33.3%) |
3 (18.7%) |
14 |
.336† |
| Yes |
22 (66.7%) |
13 (81.3%) |
35 |
| Comorbidities |
No |
33 (100%) |
11 (68.7%) |
44 |
0.002† |
| Yes |
0 (0%) |
5 (31.3%) |
5 |
| GAGS T0 |
25 (20-41) |
29 (22-36) |
27 (20-41) |
.164* |
| AQoL T0 |
61 (8-92) |
57 (10-87) |
59 (8-92) |
.393* |
| # p value<0.05; *Mann-Whitney U test for quantitative variables; †Fisher test for qualitative variables;GAGS: global acne grading system; AQoL: acne quality of life. |
|
